Evidence map›Paper›PMID 40127016›Full record

ArticleAngewandte Chemie (International ed. in English)2025

Rapid Access to Conjugated Z,Z,Z-Trienes.

Nhan Nu Hong Ton, Binh Khanh Mai, Thomas Fallon, Thanh Vinh Nguyen

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Rapid Access to Conjugated Z,Z,Z-Trienes.Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nhan Nu Hong TonSchool of Chemistry, University of New South Wales, Anzac Parade, Kensington, Sydney, NSW, 2052, Australia.
Binh Khanh MaiDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, 15260, USA.
Thomas FallonSchool of Physics, Chemistry and Earth Sciences, University of Adelaide, Adelaide, SA, 5005, Australia.
Thanh Vinh NguyenSchool of Chemistry, University of New South Wales, Anzac Parade, Kensington, Sydney, NSW, 2052, Australia.

Funding

Australian Research Council DP200100063UNSW Faculty of Science
6 · The paper itself

Abstract

Intercepting reactions have recently emerged as an innovative approach in organic synthesis, allowing chemists to harness reactive intermediates to access structures and functionalities that conventional methods cannot easily achieve. By deliberately manipulating reaction pathways, this strategy provides a unique avenue to explore unusual reactivities and complex molecular architectures. In this work, we have developed a new protocol for the nucleophile-intercepted Beckmann fragmentation reaction (NuBFr). Employing tropone oxime tosylate - a simple and readily accessible precursor - and a diverse set of nucleophiles generated in situ from alcohols, phenols, thiols and alkynes with strong bases, we successfully synthesized a library of novel conjugated Z,Z,Z-trienecarbonitrile derivatives. This method facilitates rapid access to the conjugated Z,Z,Z-triene motif, a structural feature rarely encountered in synthetic chemistry. Our computational studies indicate that the NuBFr reaction likely proceeds through the formation of a bicylic azirine intermediate. The resulting Z,Z,Z-trienecarbonitriles could undergo an unprecedented thermally induced 8π/6π/4π electrocyclization cascade sequence to produce trisubstituted olefins. This sequence underscores the fundamental value of these motifs in pushing the boundaries of unusual reactivities in organic synthesis.

Indexed as

Beckmann fragmentationConjugationInterrupted reactionPolyeneTriene

Identifiers

PMID40127016
PMCPMC12105688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.